Figures computed from official regulatory filings — .
Analysttarget 20 USD (+57%) · consensus 4.9/5 · 10 buy · 0 hold · 0 sell
Ownershipinsiders 4.47% · institutions 97.33% · short 3.2% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for NeuroPace Inc only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
8 buys69 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Morrell Martha | Other | $4.7K | SEC |
| Williams Patrick F. | Other | $16.6K | SEC |
| Becker Joel | Other | $19.3K | SEC |
| Morrell Martha | Other | $5.1K | SEC |
| Becker Joel | Other | $15.9K | SEC |
| Morrell Martha | Other | $5.4K | SEC |
| Kumar Rakhi | Award | $15.5K | SEC |
| Geiger Uri | Award | $12.3K | SEC |
| Fischer Frank M | Award | $22.9K | SEC |
| Fischer Frank M | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Andrade Lisa | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Huennekens R Scott | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Geiger Uri | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ryan Renee | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Geiger Uri | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kumar Rakhi | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ryan Renee | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Fischer Frank M | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Kumar Rakhi | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Huennekens R Scott | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Andrade Lisa | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Becker Joel | Other | $19.9K | SEC |
| Morrell Martha | Other | $6.1K | SEC |
| Becker Joel | Other | $19.2K | SEC |
| Williams Patrick F. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |